GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a significant focus in therapeutic investigation, largely due to its notable impact on treating diseases such as adult-onset diabetes and obesity. New trials have demonstrated that more than glucose management, GLP